bryan johnson bpc 157 Well said. While Johnson’s experience is just a single case (an n=1) and doesn’t establish causation the way a randomized controlled trial can, it highlights an important issue: we simply don’t An FDA Committee Just Voted

Most research on BPC-157 has been conducted in animal models with promising results related to tissue repair and inflammation balance

Animal studies using the gold-standard euglycemic clamp technique confirmed that even chronic AOD-9604 treatment produced no adverse effects on insulin sensitivity, despite significant fat loss occurring

Many users employ a strategy of using a lower, maintenance dose after an initial loading phase to save money

For Healing and Injury Recovery: BPC-157 + TB-500 This is the category he talks about most

initial results have been reported at an earlier Pernicious Anaemia Society meeting, and these presentations can be found online on the PAS website and / or YouTube

Differences in daily intake and supplemental forms can also influence their clinical use